No menu items!

Tag: MorphoSys

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial

Bayer's antibody-drug conjulate (ADC) anetumab ravtansine has failed to show improvements in the survival rates of mesothelioma patients. Stock prices of Bayer's collaborators ImmunoGen...

Popular

Land Deal Brings Major Torrevieja Hospital Expansion Closer as Population Continues to Grow

Plans to expand Torrevieja University Hospital have taken a...

Minimum Wages in 2026: Where Europe Pays the Most — and the Least

Minimum wages continue to differ sharply across Europe, leaving...

IN THE BUNKER WITH MICK THE GRIP

AFTER A TEMPORARY relocation in 2025 due to wildfires,...

FREE LUNCH SEMINAR IN QUESADA

"Questions about living in Spain? Join us for the Free...